OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 37 citing articles:

Exposure to prescribed medication in early life and impacts on gut microbiota and disease development
Huan Huang, Jiayin Jiang, Xinyu Wang, et al.
EClinicalMedicine (2024) Vol. 68, pp. 102428-102428
Open Access | Times Cited: 25

A comprehensive guide to assess gut mycobiome and its role in pathogenesis and treatment of inflammatory bowel disease
Amit K. Yadav, Renu Yadav, Vishal Sharma, et al.
Indian Journal of Gastroenterology (2024) Vol. 43, Iss. 1, pp. 112-128
Closed Access | Times Cited: 10

Probiotics for inflammatory bowel disease: Is there sufficient evidence?
Yueying Ma, Dandan Yang, Jin Huang, et al.
Open Life Sciences (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 10

Gut Microecological Prescription: A Novel Approach to Regulating Intestinal Micro-Ecological Balance
Lingping Zhu, Xuefeng Yang
International Journal of General Medicine (2025) Vol. Volume 18, pp. 603-626
Open Access | Times Cited: 1

The Gut Microbiome and Colorectal Cancer: An Integrative Review of the Underlying Mechanisms
Farah Karam, Yara El Deghel, Rabah Iratni, et al.
Cell Biochemistry and Biophysics (2025)
Open Access | Times Cited: 1

Inflammatory bowel disease and neuropsychiatric disorders: Mechanisms and emerging therapeutics targeting the microbiota-gut-brain axis
Guido Petracco, Isabella Faimann, Florian Reichmann
Pharmacology & Therapeutics (2025), pp. 108831-108831
Open Access | Times Cited: 1

Fecal Microbiota Transplantation (FMT) and Clinical Outcomes Among Inflammatory Bowel Disease (IBD) Patients: An Umbrella Review
Sheza Malik, Syed Arsalan Ahmed Naqvi, Abul Hasan Shadali, et al.
Digestive Diseases and Sciences (2025)
Open Access | Times Cited: 1

The role of the intestinal microbiome in cognitive decline in patients with kidney disease
Carsten A. Wagner, Isabelle Frey‐Wagner, Alberto Ortíz, et al.
Nephrology Dialysis Transplantation (2025) Vol. 40, Iss. Supplement_2, pp. ii4-ii17
Open Access | Times Cited: 1

Integrating multi-omics to unravel host-microbiome interactions in inflammatory bowel disease
Yiran Zhang, John P. Thomas, Tamás Korcsmáros, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 9, pp. 101738-101738
Open Access | Times Cited: 8

Long-distance microbial mechanisms impacting cancer immunosurveillance
Laurence Zitvogel, Marine Fidelle, Guido Kroemer
Immunity (2024) Vol. 57, Iss. 9, pp. 2013-2029
Closed Access | Times Cited: 7

Yerba Mate (Ilex paraguariensis) Reduces Colitis Severity by Promoting Anti-Inflammatory Macrophage Polarization
Alexandra Olate‐Briones, Sofía Albornoz-Muñoz, Francisca Rodríguez-Arriaza, et al.
Nutrients (2024) Vol. 16, Iss. 11, pp. 1616-1616
Open Access | Times Cited: 6

Current and future microbiome-based therapies in inflammatory bowel disease
Jonathan A. Montrose, Satya Kurada, Monika Fischer
Current Opinion in Gastroenterology (2024) Vol. 40, Iss. 4, pp. 258-267
Closed Access | Times Cited: 4

DAMP-ing IBD: Extinguish the Fire and Prevent Smoldering
Oliver Sandys, Pieter Stokkers, Anje A. te Velde
Digestive Diseases and Sciences (2024)
Open Access | Times Cited: 4

Current Pharmacologic Options and Emerging Therapeutic Approaches for the Management of Ulcerative Colitis: A Narrative Review
Sneha Annie Sebastian, Oroshay Kaiwan, Edzel Lorraine Co, et al.
Spartan Medical Research Journal (2024) Vol. 9, Iss. 3
Closed Access | Times Cited: 4

Das gastrointestinale Mikrobiom – Vision und Mission
Andreas Stallmach
DMW - Deutsche Medizinische Wochenschrift (2025) Vol. 150, Iss. 04, pp. 157-162
Closed Access

A practical approach to positioning therapies in ulcerative colitis
Russell Yanofsky, David T. Rubin
Journal of the Canadian Association of Gastroenterology (2025) Vol. 8, Iss. Supplement_2, pp. S6-S14
Open Access

Microbiota transplantation and administration of live biotherapeutic products for the treatment of dysbiosis-associated diseases
Samantha Flores-Treviño, Paola Bocanegra‐Ibarias, Daniel Salas‐Treviño, et al.
Expert Opinion on Biological Therapy (2025)
Closed Access

Gut Microbiota Modulation in IBD: From the Old Paradigm to Revolutionary Tools
Marco Murgiano, Bianca Bartocci, Pierluigi Puca, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 7, pp. 3059-3059
Open Access

Detecting microbial engraftment after FMT using placebo sequencing and culture enriched metagenomics to sort signals from noise
Shahrokh Shekarriz, Jake C. Szamosi, Fiona Whelan, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access

Gut microbiota development across the lifespan: Disease links and health‐promoting interventions
Ida Schoultz, Marcus J. Claesson, María Gloria Domínguez-Bello, et al.
Journal of Internal Medicine (2025)
Open Access

Engineered Tissue Models to Decode Host–Microbiota Interactions
Miryam Adelfio, G. E. Callen, Xuesong He, et al.
Advanced Science (2025)
Open Access

Beyond Antibiotics: What the Future Holds
Payam Benyamini
Antibiotics (2024) Vol. 13, Iss. 10, pp. 919-919
Open Access | Times Cited: 3

Page 1 - Next Page

Scroll to top